From cultural impact to financial recovery, his story still sparks debate about fame, legacy and second chances.
Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have entered into a definitive agreement under which Alkermes will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback